ProfileGDS4132 / 236150_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 72% 70% 78% 78% 75% 72% 78% 63% 73% 73% 68% 56% 66% 71% 67% 65% 70% 69% 70% 63% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101216.45372
GSM201543Muscle PCOS pioglitazone 121199.38370
GSM201544Muscle PCOS pioglitazone 161270.81378
GSM201545Muscle PCOS pioglitazone 201278.07178
GSM201829Muscle PCOS pioglitazone 231248.96975
GSM201830Muscle PCOS pioglitazon 251228.51872
GSM201831Muscle PCOS pioglitazone 271267.85978
GSM201832Muscle PCOS pioglitazone 31172.51263
GSM201833Muscle PCOS pioglitazone 41214.35373
GSM201834Muscle PCOS pioglitazone 81229.02773
GSM201835Muscle PCOS after pioglitazone 102190.96668
GSM201836Muscle PCOS after pioglitazone 122145.61156
GSM201837Muscle PCOS after pioglitazone 162174.44466
GSM201838Muscle PCOS after pioglitazone 202214.11671
GSM201839Muscle PCOS after pioglitazone 232191.72567
GSM201840Muscle PCOS after pioglitazone 252189.4665
GSM201841Muscle PCOS after pioglitazone 272198.43270
GSM201842Muscle PCOS after pioglitazone 32177.83569
GSM201843Muscle PCOS after pioglitazone 42206.87570
GSM201844Muscle PCOS after pioglitazone 82179.71263